HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A R Green Selected Research

disufenton sodium (NXY 059)

12/2009Emulating multicentre clinical stroke trials: a new paradigm for studying novel interventions in experimental models of stroke.
8/2009Effects of NXY-059 in experimental stroke: an individual animal meta-analysis.
1/2002Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.
3/2001Efficacy of disodium 4-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (NXY-059), a free radical trapping agent, in a rat model of hemorrhagic stroke.
1/2001NXY-059, a free radical--trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A R Green Research Topics

Disease

25Breast Neoplasms (Breast Cancer)
09/2021 - 03/2006
11Neoplasms (Cancer)
01/2016 - 02/2008
8Hyperthermia
07/2012 - 01/2001
6Stroke (Strokes)
12/2009 - 04/2000
4Neoplasm Metastasis (Metastasis)
08/2016 - 11/2011
4Leukemia
01/2014 - 01/2001
4Hypothermia
07/2010 - 01/2000
4Ischemic Stroke
03/2008 - 07/2000
3Carcinogenesis
08/2016 - 01/2013
2B-Cell Lymphoma (Lymphoma, B Cell)
09/2021 - 08/2010
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2002 - 04/2000
2Infarction (Infarctions)
01/2002 - 01/2001
2Brain Ischemia (Cerebral Ischemia)
01/2001 - 04/2000
1Drug-Related Side Effects and Adverse Reactions
06/2020
1Multiple Chronic Conditions
06/2020
1Dementia (Dementias)
06/2020
1Cognitive Dysfunction
06/2020
1Inflammation (Inflammations)
06/2017
1Carcinoma (Carcinomatosis)
04/2015
1Lipoma (Lipomata)
03/2015
1Body Weight (Weight, Body)
01/2014
1Polycythemia Vera
01/2014
1Body Temperature Changes
07/2012
1Disease Progression
11/2011
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2011
1Mental Disorders (Mental Disorder)
08/2008
1Triple Negative Breast Neoplasms
07/2008
1Thrombosis (Thrombus)
01/2008

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
01/2016 - 09/2001
9Biological ProductsIBA
09/2021 - 03/2006
8Biomarkers (Surrogate Marker)IBA
09/2021 - 03/2007
6N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
07/2012 - 01/2001
5Pharmaceutical PreparationsIBA
07/2012 - 05/2000
5disufenton sodium (NXY 059)IBA
12/2009 - 01/2001
4Hormones (Hormone)IBA
01/2014 - 11/2008
4Cadherins (E-Cadherin)IBA
01/2014 - 03/2007
4Phenobarbital (Luminal)FDA Link
10/2013 - 11/2008
4Chlormethiazole (Clomethiazole)IBA
08/2001 - 04/2000
3ErbB Receptors (EGF Receptor)IBA
09/2021 - 03/2007
3ProgesteroneFDA LinkGeneric
01/2014 - 03/2007
3Serotonin (5 Hydroxytryptamine)IBA
07/2010 - 01/2005
3Keratins (Keratin)IBA
05/2010 - 03/2007
3Free RadicalsIBA
01/2002 - 01/2001
3gamma-Aminobutyric Acid (GABA)IBA
08/2001 - 05/2000
2Phosphotransferases (Kinase)IBA
09/2021 - 01/2014
2SteroidsIBA
01/2014 - 01/2000
2Indicators and Reagents (Reagents)IBA
08/2010 - 09/2001
2Neuroprotective AgentsIBA
12/2009 - 04/2000
2TamoxifenFDA LinkGeneric
10/2009 - 02/2003
2Tissue Plasminogen Activator (Alteplase)FDA Link
03/2008 - 01/2008
2Basic Helix-Loop-Helix Transcription FactorsIBA
06/2001 - 01/2001
1Cyclin EIBA
09/2021
1MucinsIBA
09/2021
1Opiate AlkaloidsIBA
06/2020
1BenzodiazepinesIBA
06/2020
1Hypoglycemic Agents (Hypoglycemics)IBA
06/2020
1Antipsychotic Agents (Antipsychotics)IBA
06/2020
1AmmoniaIBA
06/2017
1Glycoproteins (Glycoprotein)IBA
08/2016
1Laminin (Merosin)IBA
08/2016
1Discoidin Domain ReceptorsIBA
06/2015
1KSR-1 protein kinaseIBA
04/2015
1Cell-Free Nucleic AcidsIBA
04/2015
1Checkpoint Kinase 1IBA
04/2015
1AgarIBA
04/2015
1Oncogene Proteins (Oncogene Protein)IBA
04/2015
1Transcription Factors (Transcription Factor)IBA
03/2015
1CytokinesIBA
03/2015
1cathinoneIBA
01/2014
1Ubiquitin-Conjugating EnzymesIBA
01/2014
1Histones (Histone)IBA
01/2014
1GSK1210151AIBA
01/2014
1Neoplasm Antigens (Tumor Antigens)IBA
01/2014
1Janus Kinase 2IBA
12/2013
1Hemoglobins (Hemoglobin)IBA
12/2013
1CalreticulinIBA
12/2013
1human ERBB2 proteinIBA
09/2012
1CalpainIBA
09/2012
1calpastatinIBA
09/2012
1VaccinesIBA
04/2012
1Janus KinasesIBA
03/2012
1beta Adrenergic ReceptorsIBA
11/2011
1Adrenergic Receptors (Adrenergic Receptor)IBA
11/2011
1Messenger RNA (mRNA)IBA
10/2011
1Serotonin ReceptorsIBA
07/2010
1Anastrozole (Arimidex)FDA LinkGeneric
10/2009
1Estrogen Receptor alphaIBA
10/2009
1MicroRNAs (MicroRNA)IBA
05/2009
1Antidepressive Agents (Antidepressants)IBA
08/2008
1Caveolin 1IBA
07/2008
1Caveolin 2IBA
07/2008
1Fibrinogen (Factor I)FDA Link
01/2008
1Androgen Receptors (Androgen Receptor)IBA
03/2007
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2005

Therapy/Procedure

6Therapeutics
01/2014 - 01/2000
3Drug Therapy (Chemotherapy)
09/2021 - 03/2015
1Deprescriptions
06/2020
1Activities of Daily Living (ADL)
06/2020
1Drug Tapering
06/2020
1Immunotherapy
04/2012